A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

A medical supplier has been ordered to pay millions in the largest-ever penalty in Australia for unlawfully supplying more ...

A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Strategics tend to invest in med-tech companies they are looking to acquire or could be acquired. Furthermore, companies like ...

Negotiators at Boeing and its largest union are due to resume talks over a labor contract on Tuesday, as the planemaker seeks ...

The analysis comes as regulators investigate how the FDA authorizes medical devices and handles safety recalls.

The Federal Circuit revived a lawsuit against Medtronic Inc. over guide catheter technology Monday, ruling that a district ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The past month has been quite encouraging for Medtronic MDT investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including ...